Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410) announced a private placement of round 7 unregistered coupon unguaranteed private convertible bond for gross proceeds of KRW 7,000,000,000 on January 7, 2019. The coupon rate is 1% and yield to maturity is 4%. The maturity date of bonds is January 7, 2022. The bonds are 100% convertible into 1,270,186 common shares at a conversion price of KRW 5,511 representing 3.77% stake in the company from January 7, 2020 to December 31, 2021. The transaction included participation from existing investor CnPharm Co., Ltd. for KRW 6,000,000,000 and another investor Vitamax Co., Ltd. for KRW 1,000,000,000. The transaction has been approved by the board of directors of the company.